Guidelines on bladder cancer

被引：326

作者：

Oosterlinck, W

Lobel, B

Jakse, G

Malmström, PU

Stöckle, M

Sternberg, C

机构：

[1] Ghent Univ Hosp, Dept Urol, B-9000 Ghent, Belgium

[2] CHRU Pontchaillou, Rennes, France

[3] Rhein Westfal TH Aachen, Univ Clin, D-5100 Aachen, Germany

[4] Univ Uppsala Hosp, Uppsala, Sweden

[5] Univ Saarland, D-6650 Homburg, Saar, Germany

[6] Clin Pio XI, Rome, Italy

来源：

EUROPEAN UROLOGY | 2002年 / 41卷 / 02期

关键词：

bladder cancer; superficial bladder cancer; guidelines;

D O I：

10.1016/S0302-2838(01)00026-4

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: On behalf of the European Association of Urology (EAU) guidelines for diagnosis, therapy and follow-up of bladder cancer patients were established. Criteria for recommendations were evidence based, and included aspects of cost-effectiveness and clinical feasibility. Method: A systematic literature research using Medline Services was conducted. References were weighted by a panel of experts. Results: TNM 1997 classification and WHO grading 1998 are recommended. Recommendations are developed for diagnosis for bladder cancer in general, treatment of superficial and infiltrative bladder cancer, and follow-up after different types of treatment modalities, such as intravesical instillations, radical cystectomy, urinary diversions, radiotherapy and chemotherapy. (C) 2002 Elsevier Science B.V. All rights reserved.

引用

页码：105 / 112

页数：8

共 67 条

[1]

[Anonymous], 1999, Lancet, V354, P533

[2] Prognostic factors of outcome after radical cystectomy for bladder cancer: A retrospective study of a homogeneous patient cohort [J].

Bassi, P ;

Ferrante, GD ;

Piazza, N ;

Spinadin, R ;

Carando, R ;

Pappagallo, G ;

Pagano, F .

JOURNAL OF UROLOGY, 1999, 161 (05) :1494-1497

[3] Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium [J].

Bellmunt, J ;

Guillem, V ;

Paz-Ares, L ;

González-Larriba, JL ;

Carles, J ;

Batiste-Alentorn, E ;

Sáenz, A ;

López-Brea, M ;

Font, A ;

Nogué, M ;

Bastús, R ;

Climent, MA ;

de la Cruz, JJ ;

Albanell, J ;

Banús, JM ;

Gallardo, E ;

Diaz-Rubio, E ;

Cortés-Funes, H ;

Baselga, J .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) :3247-3255

[4] Continent urinary diversion [J].

Benson, MC ;

Olsson, CA .

UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (01) :125-+

[5] INTRAVESICAL ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - RESULTS OF 2 EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER RANDOMIZED TRIALS WITH MITOMYCIN-C AND DOXORUBICIN COMPARING EARLY VERSUS DELAYED INSTILLATIONS AND SHORT-TERM VERSUS LONG-TERM TREATMENT [J].

BOUFFIOUX, C ;

KURTH, KH ;

BONO, A ;

OOSTERLINCK, W ;

KRUGER, CB ;

DEPAUW, M ;

SYLVESTER, R ;

DENIS, L ;

NEWLING, D ;

HALL, R ;

BRESSEL, M ;

CASSELMAN, J ;

SMITH, P ;

ROBINSON, M ;

KEUPPENS, F ;

TOLLEY, D ;

JAKSE, G ;

BOLLACK, C ;

VERGISON, B ;

HOEKSTRA, W ;

DASILVA, FC ;

GROEN, J ;

RICHARDS, B ;

PAVONEMACALUSO, M ;

VANDERMEIJDEN, A ;

ZWARTENDIJK, H ;

JACOBI, G ;

VANCAUBERG, R ;

SCHRODER, F ;

HIRDES, D ;

LEISINGER, H ;

RIEDL, H ;

LUDWIG, P ;

ROOZENDAAL, K ;

MARECHAL, L ;

VANAUBEL, O ;

CONSIDINE, J ;

DEBRUYNE, F ;

CARREIRA, F ;

DEWALL, D ;

MENSINK, H ;

VIGGIANO, G .

JOURNAL OF UROLOGY, 1995, 153 (03) :934-941

[6] Second resection and prognosis of primary high risk superficial bladder cancer: Is cystectomy often too early? [J].

Brauers, A ;

Buettner, R ;

Jakse, G .

JOURNAL OF UROLOGY, 2001, 165 (03) :808-810

[7]

CLARK PB, 1984, J UROLOGIE, V90, P173

[8] The treated natural history of high risk superficial bladder cancer: 15-year outcome [J].

Cookson, MS ;

Herr, HW ;

Zhang, ZF ;

Soloway, S ;

Sogani, PC ;

Fair, WR .

JOURNAL OF UROLOGY, 1997, 158 (01) :62-67

[9] Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation [J].

Coppin, CML ;

Gospodarowicz, MK ;

James, K ;

Tannock, IF ;

Zee, B ;

Carson, J ;

Pater, J ;

Sullivan, LD .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) :2901-2907

[10] Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer [J].

Donat, SM ;

Herr, HW ;

Bajorin, DF ;

Fair, WR ;

Sogani, PC ;

Russo, P ;

Sheinfeld, J ;

Scher, HI .

JOURNAL OF UROLOGY, 1996, 156 (02) :368-371

← 1 2 3 4 5 6 7 →